Yahoo Finance

Transpire Bio’s ANDA for Generic Trelegy® Ellipta® Accepted for Filing by the U.S. FDA

SUNRISE, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, ...
Pharmabiz

China NMPA approves GSK’s Trelegy Ellipta for use in adults with uncontrolled asthma

GSK plc announced that China’s National Medical Products Administration (NMPA) has approved a new indication for Trelegy Ellipta (fluticasone furoate/umeclidinium ...
Mena FN

Transpire Bio's ANDA For Generic Trelegy® Ellipta® Accepted For Filing By The U.S. FDA

(MENAFN- GlobeNewsWire - Nasdaq) SUNRISE, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for ...
Pharmabiz

US FDA accepts filing of Transpire Bio’s ANDA for generic Trelegy Ellipta

Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, announces that its abbreviated new drug ...